Luis Cirera

549 total citations
23 papers, 423 citations indexed

About

Luis Cirera is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Luis Cirera has authored 23 papers receiving a total of 423 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 13 papers in Pulmonary and Respiratory Medicine and 4 papers in Cancer Research. Recurrent topics in Luis Cirera's work include Colorectal Cancer Treatments and Studies (7 papers), Cancer Treatment and Pharmacology (6 papers) and Gastric Cancer Management and Outcomes (6 papers). Luis Cirera is often cited by papers focused on Colorectal Cancer Treatments and Studies (7 papers), Cancer Treatment and Pharmacology (6 papers) and Gastric Cancer Management and Outcomes (6 papers). Luis Cirera collaborates with scholars based in Spain, Netherlands and Chile. Luis Cirera's co-authors include Eugeni Saigí, Àngels Arcusa, Ignacio Tusquets, Ignasi Guasch, A. Balil, E. Batiste-Alentorn, José Carlos Benítez, Marc Campayo, Mariano Monzó and Alfons Navarro and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Annals of Oncology.

In The Last Decade

Luis Cirera

22 papers receiving 407 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Luis Cirera Spain	10	194	172	75	67	59	23	423
Yannan Yuan China	9	112 0.6×	108 0.6×	54 0.7×	78 1.2×	30 0.5×	20	340
Chloe Friedman United States	11	227 1.2×	160 0.9×	41 0.5×	202 3.0×	50 0.8×	35	432
Deog Gon Cho South Korea	15	140 0.7×	311 1.8×	55 0.7×	201 3.0×	9 0.2×	36	533
Hongkai Zhang China	12	57 0.3×	82 0.5×	23 0.3×	146 2.2×	48 0.8×	60	402
Jin Won Lee South Korea	8	150 0.8×	139 0.8×	45 0.6×	97 1.4×	33 0.6×	11	351
Daojuan Li China	15	169 0.9×	144 0.8×	103 1.4×	79 1.2×	50 0.8×	39	485
Erna Busch United States	10	187 1.0×	126 0.7×	133 1.8×	74 1.1×	93 1.6×	11	501
David Hart Australia	9	104 0.5×	335 1.9×	13 0.2×	66 1.0×	38 0.6×	14	468
Ivan Rashid Italy	9	141 0.7×	146 0.8×	42 0.6×	113 1.7×	23 0.4×	22	387
Adrian G. Dan United States	12	252 1.3×	102 0.6×	43 0.6×	313 4.7×	5 0.1×	33	552

Countries citing papers authored by Luis Cirera

Since Specialization

Citations

This map shows the geographic impact of Luis Cirera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luis Cirera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luis Cirera more than expected).

Fields of papers citing papers by Luis Cirera

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luis Cirera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luis Cirera. The network helps show where Luis Cirera may publish in the future.

Co-authorship network of co-authors of Luis Cirera

This figure shows the co-authorship network connecting the top 25 collaborators of Luis Cirera. A scholar is included among the top collaborators of Luis Cirera based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luis Cirera. Luis Cirera is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Benítez, José Carlos, Marc Campayo, Tania Díaz, et al.. (2021). Lincp21-RNA as Predictive Response Marker for Preoperative Chemoradiotherapy in Rectal Cancer. Journal of Personalized Medicine. 11(5). 420–420. 5 indexed citations

Valladares‐Ayerbes, Manuel, Pilar García‐Alfonso, Juan Jesús Cruz, et al.. (2019). Sequential RAS mutation testing in cfDNA in RAS wild type (wt) metastatic colorectal cancer (mCRC) patients (pt) treated with panitumumab (P) and chemotherapy (CT) in first-line (1L): PERSEIDA study. Annals of Oncology. 30. v202–v202. 1 indexed citations

Benítez, José Carlos, et al.. (2018). Leptomeningeal Carcinomatosis in a Patient With Clinical Stage III Lung Adenocarcinoma and Sudden Neurological Impairment. Archivos de Bronconeumología. 54(6). 344–345.

Campayo, Marc, Alfons Navarro, José Carlos Benítez, et al.. (2018). miR-21, miR-99b and miR-375 combination as predictive response signature for preoperative chemoradiotherapy in rectal cancer. PLoS ONE. 13(11). e0206542–e0206542. 36 indexed citations

Pericay, Carles, Ferrán Losa, Luis Cirera, et al.. (2016). Phase II study with docetaxel (D), cisplatin (C) and continuous capecitabine (X) schedule (DCX) in advanced gastric cancer (AGC): ML21085. Final results.. Journal of Clinical Oncology. 34(15_suppl). e15520–e15520. 1 indexed citations

Pericay, Carles, Vicente Alonso, Antonieta Salud, et al.. (2014). Biweekly cetuximab in combination with FOLFOX-4 in the first-line treatment of wild-type KRASmetastatic colorectal cancer: final results of a phase II, open-label, clinical trial (OPTIMIX-ACROSS Study). BMC Cancer. 14(1). 865–865. 19 indexed citations

Múñoz, Alberto, Carles Pericay, Carlos García Girón, et al.. (2014). Phase II Study of Bevacizumab, Capecitabine, and Oxaliplatin Followed by Bevacizumab Plus Erlotinib as First-Line Therapy in Metastatic Colorectal Cancer. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics. 21(4). 181–191. 7 indexed citations

Puente, Javier, Sara López‐Tarruella, Amparo Ruı́z, et al.. (2010). Practical prognostic index for patients with metastatic recurrent breast cancer: retrospective analysis of 2,322 patients from the GEICAM Spanish El Alamo Register. Breast Cancer Research and Treatment. 122(2). 591–600. 36 indexed citations

Alonso, Vicente, Carles Pericay, P. Escudero, et al.. (2010). Cetuximab Given Every 2 Weeks plus Irinotecan Is an Active and Safe Option for Previously Treated Patients with Metastatic Colorectal Cancer. Chemotherapy. 56(2). 142–146. 18 indexed citations

10.

Cirera, Luis, et al.. (2006). Impacto clínico de la PET con 18FDG en la selección de la terapia de los pacientes oncológicos. 29(4). 2 indexed citations

11.

Cirera, Luis, Ramón Rami–Porta, R. Bastús, et al.. (2006). Routine positron emission tomography (PET) and selective mediastinoscopy is as good as routine mediastinoscopy to rule out N2 disease in non-small cell lung cancer (NSCLC). Journal of Clinical Oncology. 24(18_suppl). 7031–7031. 11 indexed citations

12.

Salud, Antonieta, E. Batiste-Alentorn, Ferrán Losa, et al.. (2004). Randomized phase IV trial of oral tegafur and low dose leucovorin versus intravenous 5-fluorouracil and leucovorin in the treatment of advanced colorectal cancer (ACC): Final results. Journal of Clinical Oncology. 22(14_suppl). 3547–3547. 4 indexed citations

13.

Barnadas, Agustí, et al.. (2004). Primary hormonal therapy with exemestane in patients with breast tumors >3 cm in diameter: Results of a Spanish multicenter phase II trial. Journal of Clinical Oncology. 22(14_suppl). 603–603. 3 indexed citations

14.

Barnadas, Agustí, Luis Cirera, Ignasi Tusquets, et al.. (2004). Primary hormonal therapy with exemestane in patients with breast tumors >3 cm in diameter: Results of a Spanish multicenter phase II trial. Journal of Clinical Oncology. 22(14_suppl). 603–603. 12 indexed citations

15.

Ballester, Ferrán, Marc Sáez, Santiago Pérez‐Hoyos, et al.. (2002). The EMECAM project: a multicentre study on air pollution and mortality in Spain: combined results for particulates and for sulfur dioxide. Occupational and Environmental Medicine. 59(5). 300–308. 65 indexed citations

16.

Peterson, Patrick, et al.. (2001). Incidence of thrombocytopenia with gemcitabine-based therapy and influence of dosing and schedule. Anti-Cancer Drugs. 12(4). 383–385. 6 indexed citations

17.

Caballero, Javier Martínez, et al.. (1999). Small Cell Carcinoma of the Urinary Bladder Treated with Chemotherapy and Radiotherapy: Results in Five Cases. European Urology. 35(4). 323–326. 45 indexed citations

18.

Cirera, Luis, A. Balil, E. Batiste-Alentorn, et al.. (1999). Randomized Clinical Trial of Adjuvant Mitomycin Plus Tegafur in Patients With Resected Stage III Gastric Cancer. Journal of Clinical Oncology. 17(12). 3810–3815. 88 indexed citations

19.

Vadell, Catalina, Miguel Ángel Seguí, Serafín Morales, et al.. (1998). Anticachectic Efficacy of Megestrol Acetate at Different Doses and Versus Placebo in Patients With Neoplastic Cachexia. American Journal of Clinical Oncology. 21(4). 347–351. 41 indexed citations

20.

Morales, Serafín, et al.. (1993). Alternating Chemotherapy in Advanced Non-Small Cell Lung Cancer: A Phase II Study. Oncology. 50(4). 235–237. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact